| Greeson, JM; Sanford, B; Monti, DA Feb 2001 | Hyperforin is a prenylated phloroglucinol derivative |
|---|---|
| Flora of North America taxon ID:• Composition of the essential oils of Hypericum perforatum L | Botanical Society of Britain and Ireland |
A review of the recent advances in its pharmacology".
3| Database of Tracheophytes of Metropolitan France and neighbouring regions:• | "Hypericum perforatum St John's Wort : a non-selective reuptake inhibitor? British Journal of Clinical Pharmacology |
|---|---|
| [57] to test the effectivity of hyperforin in a rat model of experimental allergic encephalomyelitis EAE | "Herbal product-drug interactions mediated by induction" |
The structure of hyperforin was elucidated by a research group from the Shemyakin Institute of Bio-organic Chemistry USSR Academy of Sciences in Moscow and published in 1975.
| John's wort Hypericum perforatum : a review of the current pharmacological, toxicological, and clinical literature" | Kumar V, Mdzinarishvili A, Kiewert C, Abbruscato T, Bickel U, van der Schyf CJ, Klein J 2006 |
|---|---|
| "Skin tolerance of a new bath oil containing St | Anti-inflammatory mechanisms of hyperforin have been described as inhibition of cyclooxygenase-1 but not COX-2 and 5-lipoxygenase at low concentrations of 0 |
Nahrstedt A, Butterweck V 1997.
6